Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study.
Swain SM, Ewer MS, Viale G, Delaloge S, Ferrero JM, Verrill M, Colomer R, Vieira C, Werner TL, Douthwaite H, Bradley D, Waldron-Lynch M, Kiermaier A, Eng-Wong J, Dang C; BERENICE Study Group. Swain SM, et al. Among authors: colomer r. Ann Oncol. 2018 Mar 1;29(3):646-653. doi: 10.1093/annonc/mdx773. Ann Oncol. 2018. PMID: 29253081 Free PMC article. Clinical Trial.
Mitomycin-C and vinblastine in advanced breast cancer.
Navarro M, Bellmunt J, Balañá C, Colomer R, Jolis L, del Campo JM. Navarro M, et al. Among authors: colomer r. Oncology. 1989;46(3):137-42. doi: 10.1159/000226702. Oncology. 1989. PMID: 2497417 Review.
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization.
Arranz R, García-Alfonso P, Sobrino P, Zamora P, Carrión R, García-Laraña J, Pérez G, López J, Lavilla E, Lozano M, Rayón C, Colomer R, Barón MG, Flores E, Pérez-Manga G, Fernández-Rañada JM. Arranz R, et al. Among authors: colomer r. J Clin Oncol. 1998 Apr;16(4):1538-46. doi: 10.1200/JCO.1998.16.4.1538. J Clin Oncol. 1998. PMID: 9580385 Clinical Trial.
Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification.
Menendez JA, Vellon L, Colomer R, Lupu R. Menendez JA, et al. Among authors: colomer r. Ann Oncol. 2005 Mar;16(3):359-71. doi: 10.1093/annonc/mdi090. Epub 2005 Jan 10. Ann Oncol. 2005. PMID: 15642702 Free article.
206 results